Natalizumab and the role of α₄-integrin antagonism in the treatment of multiple sclerosis

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.7, Iss.1, 2007-01, pp. : 123-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic value ofalpha-4 integrin blockade in inflammatory bowel disease:the role of natalizumab

By Ghosh Subrata

Expert Opinion on Biological Therapy, Vol. 3, Iss. 6, 2003-09 ,pp. : 995-1000

Informa Healthcare

Access to resources Recommend Favorite

Natalizumab for multiple sclerosis: appraising risk versus benefit, a seemingly demanding tango

By Gupta Sahil Weinstock-Guttman Bianca

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 115-126

Informa Healthcare

Access to resources Recommend Favorite

Interferon-&bgr;_1a for the treatment of multiple sclerosis

By Clerico Marinella Contessa Giulia Durelli Luca

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 535-542

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β treatment for relapsing multiple sclerosis

By Weinstock-Guttman Bianca Ramanathan Murali Zivadinov Robert

Expert Opinion on Biological Therapy, Vol. 8, Iss. 9, 2008-09 ,pp. : 1435-1447

Informa Healthcare

Access to resources Recommend Favorite

The polymorphisms of the TNF-α gene in multiple sclerosis?—a meta-analysis

By Xu Lidan Yuan Weiguang Sun Haiming Zhang Xuelong Jia Xueyuan Shen Chao Zhao Yanling Sun Donglin Yu Yang Jin Yan Fu Songbin

Molecular Biology Reports, Vol. 38, Iss. 6, 2011-08 ,pp. : 4137-4144

Springer Publishing Company

Access to resources Recommend Favorite